TOKYO--(BUSINESS WIRE)--Milliman, Inc., a leading global actuarial consulting firm, announced that it has obtained Type II certification as a "Certified Pseudonymized Medical Information User" in Japan. This certification is based on Japan's "Act on Anonymized and Pseudonymized Medical Information for Research and Development in the Medical Field (Next Generation Medical Infrastructure Act)," which was amended and enacted in April 2024. (nintei2026-07.pdf) This certification enables the safe ut